These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2199180

  • 1. [Treatment of primary osteoporosis with calcium and salmon calcitonin].
    Ringe JD.
    Dtsch Med Wochenschr; 1990 Aug 03; 115(31-32):1176-82. PubMed ID: 2199180
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L, Kettenbach J, Kiener H, Graninger W, Kainberger F, Pietschmann P.
    Wien Klin Wochenschr; 1997 Apr 25; 109(8):270-4. PubMed ID: 9163888
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
    Healey JH, Paget SA, Williams-Russo P, Szatrowski TP, Schneider R, Spiera H, Mitnick H, Ales K, Schwartzberg P.
    Calcif Tissue Int; 1996 Feb 25; 58(2):73-80. PubMed ID: 8998681
    [Abstract] [Full Text] [Related]

  • 5. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
    Agnusdei D, Gonnelli S, Camporeale A, Batignani T, Nardi P, Ianes A, Gennari C.
    Minerva Endocrinol; 1989 Feb 25; 14(3):169-76. PubMed ID: 2695815
    [Abstract] [Full Text] [Related]

  • 6. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D, Marie P, Berhel M, Caulin F.
    Int J Clin Pharmacol Res; 1986 Feb 25; 6(2):157-62. PubMed ID: 3522444
    [Abstract] [Full Text] [Related]

  • 7. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 8. Estimated long-term effect of calcitonin treatment in acute osteoporotic spine fractures.
    Resch H, Pietschmann P, Willvonseder R.
    Calcif Tissue Int; 1989 Oct 01; 45(4):209-13. PubMed ID: 2509007
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
    Tóth E, Csupor E, Mészáros S, Ferencz V, Németh L, McCloskey EV, Horváth C.
    Bone; 2005 Jan 01; 36(1):47-51. PubMed ID: 15664001
    [Abstract] [Full Text] [Related]

  • 11. Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients.
    Atbinici H, Sipahioğlu S, Aksoy N, Baykara İ, Işıkan UE.
    Acta Orthop Traumatol Turc; 2015 Jan 01; 49(2):160-5. PubMed ID: 26012937
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stitt LW, Adachi JD, Taves DH, Drost D.
    J Clin Endocrinol Metab; 1997 Feb 01; 82(2):620-8. PubMed ID: 9024265
    [Abstract] [Full Text] [Related]

  • 13. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.
    Pun KK, Chan LW.
    Clin Ther; 1989 Feb 01; 11(2):205-9. PubMed ID: 2660996
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of mineral metabolism and bone turnover in osteoporotic females treated with phosphorus and salmon calcitonin.
    Cantatore FP, Carrozzo M, Magli DM, D'Amore M, Pipitone V.
    Clin Rheumatol; 1987 Dec 01; 6(4):504-9. PubMed ID: 3502402
    [Abstract] [Full Text] [Related]

  • 15. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy.
    Peichl P, Rintelen B, Kumpan W, Bröll H.
    Gynecol Endocrinol; 1999 Feb 01; 13(1):7-14. PubMed ID: 10368793
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
    Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, de Longueville M, Franchimont P.
    Am J Med; 1995 May 01; 98(5):452-8. PubMed ID: 7733123
    [Abstract] [Full Text] [Related]

  • 17. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P, Birmingham J, Kelly P, Kempler S, Nguyen T, Pocock N, Eisman J.
    N Engl J Med; 1993 Jun 17; 328(24):1747-52. PubMed ID: 7684512
    [Abstract] [Full Text] [Related]

  • 18. [Salmon calcitonin in osteoporosis. The effect of intranasal application on bone mineral content and fracture frequency in postmenopausal women with manifest osteoporotic changes].
    Overgaard K, Ravn P, Hansen MA, Christiansen C.
    Ugeskr Laeger; 1993 Aug 02; 155(31):2387-91. PubMed ID: 8346588
    [Abstract] [Full Text] [Related]

  • 19. Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.
    Reginster JY, Denis D, Deroisy R, Lecart MP, De Longueville M, Zegels B, Sarlet N, Noirfalisse P, Franchimont P.
    J Bone Miner Res; 1994 Jan 02; 9(1):69-73. PubMed ID: 8154311
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB, Fraher LJ, Ostbye T, Adachi JD, Steer BM.
    J Clin Invest; 1993 Mar 02; 91(3):1138-48. PubMed ID: 8450043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.